Lead concentrations in human plasma, urine and whole blood

Scandinavian Journal of Work, Environment and Health

Volumn 23, Issue 5, 1997, Pages 359-363

  Bergdahl, Ingvar A ^a   Schütz, Andrejs ^a   Gerhardsson, Lars ^a   Jensen, Anker ^b   Skerfving, Staffan ^a  

^a LUND UNIVERSITY   (Sweden)

^b BAD Gesundheitsvorsorge S   (Germany)

Author keywords

Biological monitoring; Inductively coupled plasma mass spectrometry; Serum

Indexed keywords

LEAD;

ACCURACY; ADULT; ARTICLE; BLOOD SAMPLING; HUMAN; HUMAN TISSUE; LEAD BLOOD LEVEL; MALE; MASS SPECTROMETRY; METAL INDUSTRY; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; URINE LEVEL;

EID: 0030702950     PISSN: 03553140     EISSN: None     Source Type: Journal    
DOI: 10.5271/sjweh.232     Document Type: Article

References (17)

1. Desilva PE. Determination of lead in plasma and studies on its relationship to lead in erythrocytes. Br J Ind Med 1981;38: 209-17.
2. Schütz A, Bergdahl IA, Ekholm A, Skerfving S. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup Environ Med 1996;53:736-40.
3. Sakai T, Yanagihara S, Kunugi Y, Ushio K. Relationships between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D. Br J Ind Med 1982;39:382-7.
4. Bergdahl IA, Schütz A, Grubb A. Application of liquid chromatography-inductively coupled plasma mass spectrometry to the study of protein-bound lead in human erythrocytes. J Anal At Spectrom 1996;11:735-8.
5. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S. δ-aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 1981;45:223-229.
6. Astrin KH, Bishop DF, Wetmur JG, Kaul B, Davidow B, Desnick RJ. δ-aminolevulinic acid dehydratase isozymes and lead toxicity. Ann NY Acad Sci 1987;514:23-39.
7. Wetmur JG, Lehnert G, Desnick RJ. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991;56:109-19.
8. Wetmur JG. Influence of the common human δ-aminolevulinate dehydratase polymorphism on lead body burden. Environ Health Perspect 1994;102 suppl 3:215-9.
9. Börjesson J, Gerhardsson L, Schütz A, Mattsson S, Skerfving S, Österberg K. In vivo measurements of lead in fingerbone in active and retired lead smelters, Int Arch Occup Environ Health 1997;69:97-105.
10. 2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991;49:757-63.
11. Araki S, Murata K, Yokoyama K, Yanagihara S, Niinuma Y, Yamamoto R, et al. Circadian rhythms in the urinary excretion of metal and organic substances in "healthy" men. Arch Environ Health 1983;38:360-6.
12. Clarkson TW, Kench JE. Uptake of lead by human erythrocytes in vitro. Biochemistry 1958;69:432-9.
13. Manton WI, Cook JD. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Br J Ind Med 1984;41:313-9.
14. Campbell BC, Meredith PA, Moore MA, Watson WS. Kinetics of lead following intravenous administration in man. Toxicol Lett 1984;21:231-5.
15. Barton JC. Retention of radiolead by human erythrocytes in vitro. Toxicol Appl Pharmacol 1989;99:314-22.
16. Simons T. Lead transport and binding by human erythrocytes in vitro. Pflügers Arch 1993;423:307-13.
17. Hirata M, Yoshida T, Miyajima K, Kosaka H, Tabuchi T. Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers Int Arch Occup Environ Health 1995;68:58-63.